SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2908Nice premium. I've been holding for a while, so sometimes patience is rewardBiomaven-9/17/2010
2907Inevitable, I guess: AMSTERDAM (Reuters) - U.S. health care company Johnson &amnigel bates-9/17/2010
2906Beats me. Cheers, Tucktuck-9/8/2010
2905Tuck; Thanks. What puzzles me is why would 78 million shares traded between 9.7Steve Lokness-9/8/2010
2904I wonder if down 20% since the IPO outperformed biotech :) The stock was in trkrw-9/8/2010
2903First, congrats to you . . . this is at least one of your charity pickstuck-9/8/2010
2902Sure a lot of shares going off above the buyout price. 65 million traded so far Steve Lokness-9/8/2010
2901IPO was at $12.keokalani'nui-9/8/2010
2900Ah, darn. Well then, congrats on being the (sort of) online champion for the coscaram(o)uche-9/8/2010
2899Big congrats to anyone who owned it. Sadly not me :) rkrw-9/7/2010
2898Sadly, Tuck's Mom hasn't owned ZGEN for a while. C'est larvae. Chetuck-9/7/2010
2897Congrats, Tuck's mom!......... BMY munches ZGEN, $9.75/share. (ZGEN muncscaram(o)uche-9/7/2010
2896Leerink thinks Genzyme will fetch $80/share in a deal that will close in 6 monthtuck-9/3/2010
2895Another privately held biotech munched... Pfizer to Acquire FoldRx PharmaceuticIan@SI-9/1/2010
2894It's official Sanofi-Aventis offers $18.5 billion for Genzyme Sanofi-Aventisrichardred-8/29/2010
28934:15PM Trubion Pharma to be acquired by Emergent BioSolutions (EBS) for total coIan@SI-8/12/2010
2892Didn't take Tang long at all after he got control: <i>Penwest PharmacBiomaven-8/9/2010
2891LONDON, Aug 3 (Reuters) - British drugmaker Shire Plc plans to buy Belgium'snigel bates-8/3/2010
2890All that turned up in a quick Google search was this from last year: seekingalpBiomaven-7/21/2010
2889Sorta on topic: Law firms "investigating claims for shareholders." Jutuck-7/21/2010
2888LLY-Alnara. No price mentioned. But this is the program from the old Altus pickerkrw-7/2/2010
2887BOSTON (Reuters) - U.S. biotechnology company Celgene Corp (NasdaqGS:CELG - Newskeokalani'nui-7/1/2010
2886SNY munches TargeGen, probably based in large part on TG 101348 and the JAK progBiotech Jim-6/30/2010
2885Marley Seaman, AP Health Writer, On Wednesday June 30, 2010, 7:18 am NEW YORK (Atom pope-6/30/2010
2884Hospira Announces Intention to Complete Tender Offer for Shares of Javelin Pharmtuck-6/29/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News